You are here: Home

Welcome to The Alliance for NanoHealth

Document Actions
FDA - ANH Banner

The Alliance for NanoHealth (ANH) was the first multi-disciplinary, multi-institutional collaborative research endeavor aimed solely at using nanotechnology to bridge the gaps between medicine, biology, materials science, computer technology and public policy. The mission of the Alliance is to collectively bridge the disciplines to develop nanotechnology-based solutions to unresolved problems in medicine. Its principal goal is to provide new clinical approaches to saving lives through better diagnosis, treatment, and prevention.

The ANH comprises eight world-class research institutions, scientists and clinicians located within the world’s largest collection of healthcare facilities, namely the Texas Medical Center and the greater Houston region. Member institutions include the Baylor College of Medicine, The University of Texas M.D. Anderson Cancer Center, Rice University, the University of Houston, The University of Texas Health Science Center at Houston, Texas A&M University, University of Texas Medical Branch and The Methodist Hospital Research Institute.

ANH institutions are committed to develop and apply nanotechnology tools in the battle against heart disease, cancer, diabetes, stroke, and infection. The willingness to share strengths among the disciplines with educational and training activities as well as welcoming new scientific associations provides a rich collaborative foundation upon which the ANH has established a wealth of research and development opportunities.

Become A Founding Corporate Member of The Alliance for NanoHealthBecome A Founding Corporate Member of The Alliance for NanoHealth

Nanotechnology News

Secret ingredient: nanoparticles aid bone growth

Nanotube-reinforced material produces denser bone tissue In the first study of its kind, bioengineers and bioscientists at Rice University and Radboud University in Nijmegen, Netherlands, have shown they can grow denser bone tissue by sprinkling stick-like nanoparticles throughout the porous material used to pattern the bone.

Researchers from UTMB detail findings in gene therapy

A new study by UTMB researchers published in Gene Therapy (”Composition of PLGA and PEI/DNA nanoparticles improves ultrasound-mediated gene delivery in solid tumors in vivo”) states: “We found that the combination of PLGA/PEI/DNA nanoparticles with ultrasonication substantially enhanced tumor cell transfection in vivo. The overexpression of beta-gal gene was evaluated histochemically and by Western blot analysis.” The study was conducted by Olga.V. Chumakova and colleagues of UTMB’s Center for Biomedical Engineering.

Nanoparticle-Induced Heating Boosts Antitumor Radiation Therapy

Radiation therapy is a time-honored and effective component of modern cancer therapy, but its ultimate utility is limited by the fact that some cancer cells are resistant to ionizing radiation. Now, a research team led by Sunil Krishnan, M.D., of the University of Texas M.D. Anderson Cancer Center, has found that pretreating tumors with gold nanoparticles and near-infrared radiation dramatically improves the response of tumors to radiation therapy.

more news...
ANH Institutions
     
 
« August 2008 »
Su Mo Tu We Th Fr Sa
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31
 
     
Spotlight
The ANH Website is honored as Biomat.net's June 2007 Top Site.